Shattuck Labs STTK
NASDAQ STTK
$6.79 -0.17 (-2.44%)
As of: Sep 4, 2026 · 3:59 PM EDT

Shattuck Labs (STTK) Free Cash Flow (2019 - 2026)

Shattuck Labs (STTK) posted quarterly Free Cash Flow of -$13.5 million for Q1 2026, down 12.09% year-over-year from -$15.3 million in Q1 2025, and down 58.86% quarter-over-quarter from -$8.5 million in Q4 2025.

Analysis

Shattuck Labs (STTK) Free Cash Flow (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has reported Free Cash Flow for 8 consecutive years, with -$13.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Free Cash Flow fell 12.09% year-over-year to -$13.5 million; the TTM figure through Mar 2026 stood at -$41.4 million (up 26.64% YoY), while the FY2025 annual figure was -$40.0 million, up 34.04% from the prior year.
  • Free Cash Flow eased to -$13.5 million in Q1 2026 per STTK's latest filing, from -$8.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$8.5 million in Q4 2025 and bottomed at -$38.8 million in Q3 2022.
  • Historically, Free Cash Flow has averaged -$17.8 million across 5 years, with a median of -$16.2 million in 2024.
  • Annual changes were most pronounced in 2022 — Free Cash Flow plunged 159.89% — and 2023, when it surged 56.83%.
  • Shattuck Labs' Free Cash Flow stood at -$24.5 million in 2022, then advanced by 20.78% to -$19.4 million in 2023, then gained by 10.63% to -$17.4 million in 2024, then surged by 51.12% to -$8.5 million in 2025, then tumbled by 58.86% to -$13.5 million in 2026.
  • Business Quant data shows STTK's Free Cash Flow at -$13.5 million in Q1 2026, -$8.5 million in Q4 2025, and -$9.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 Shattuck Labs 885.09 Mn 885.09 Mn - -10.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.26 Mn
Mar 31, 2026 -13.49 Mn
Dec 31, 2025 -8.49 Mn
Sep 30, 2025 -9.00 Mn
Jun 30, 2025 -10.43 Mn
Mar 31, 2025 -12.03 Mn
Dec 31, 2024 -17.37 Mn
Sep 30, 2024 -16.11 Mn
Jun 30, 2024 -10.94 Mn
Mar 31, 2024 -16.16 Mn
Dec 31, 2023 -19.44 Mn
Sep 30, 2023 -16.75 Mn
Jun 30, 2023 -18.83 Mn
Mar 31, 2023 -26.62 Mn
Dec 31, 2022 -24.53 Mn
Sep 30, 2022 -28.81 Mn
Jun 30, 2022 -24.00 Mn
Mar 31, 2022 -28.77 Mn
Dec 31, 2021 -20.71 Mn
Sep 30, 2021 -13.96 Mn